Lubrizol Life Science has developed a novel peptide that is designed to emulate the skin benefits offered by microcurrent devices, specifically targeting upper facial lifting effects. In vitro, it has been demonstrated to activate the same biological functions as microcurrent stimulation: improving dermal contraction and muscle tone
In an era marked by advancing technology within an evolving landscape, the burgeoning demand for performance-driven skin care technology tools and devices persists. Convenient, at-home microcurrent devices have seen a surge in popularity, likely stemming from consumer interest in non-surgical medical aesthetic treatments.
However, the steep cost and apprehensions regarding safety issues such as potential skin damage, irritation, or discomfort may pose significant barriers, compelling consumers to seek more accessible topic alternatives that replicate comparable effects in an efficient and gentle manner
Microcurrent devices leverage low electrical signals, typically less than 1000 mA, to effectively combat aging indicators such as facial sagging and wrinkles, yielding remarkable outcomes. These signals prompt cellular responses across various skin layers. Within the dermis, microcurrents stimulate enhanced extracellular matrix production and dermal contraction capabilities. Simultaneously, at the muscular level, they contribute to elevating the tonicity of facial muscles
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.